Eli Samaha sold $5.8M of Theravance Biopharma (TBPH)

Executed Jun 29, disclosed Jul 1, 2 days later.

Value, as filed

$5.8M

336,697 sh across 3 lots

Executed

Jun 29

the trade date, as filed

Disclosed

Jul 1

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Eli Samaha Director profile →

Eli Samaha (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Stagwell Inc. (STGW). The largest single filing was $5.8M of TBPH (336,697 sh across 3 lots, as filed), executed Jun 29.

The name

TBPH Theravance Biopharma, Inc. TBPH · Healthcare · 10 filings in 24 months ticker →

Healthcare · Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→